APOB and metabolic dysfunction-associated steatohepatitis: In obese human subjects with NASH, hepatic MDM2 levels significantly correlated with circulating ApoB levels (r = −0.5068, p = 0.0059) (Figure S4 and Table S1, Supporting Information), suggesting that MDM2 is inversely associated with TG‐VLDL in MAFLD.